Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Horvath, Beata | Szapary, Laszlo | Debreceni, Laszlo | Feher, Gergely | Kenyeres, Peter | Fulop, Adrienn | Battyani, Istvan | Toth, Kalman;
Affiliations: 1st Department of Medicine, Division of Cardiology, Medical School, University of Pecs, Pecs, Hungary | Department of Neurology, Medical School, University of Pecs, Pecs, Hungary | Department of Radiology, Medical School, University of Pecs, Pecs, Hungary | Consultant Internist, Medical School, University of Pecs, Pecs, Hungary
Note: [] Corresponding author: Prof. Kalman Toth, MD, ScD, 1st Department of Medicine, Medical School, University of Pecs, 7624 Pecs, Ifjusag u. 13., Hungary. Tel.: +36 72 536 145; Fax: +36 72 536 146; E-mail: kalman.toth@aok.pte.hu.
Abstract: In our prospective study the effect of Sclerovit (0.8 mg folic acid, 20 μg vitamin B12,5 mg vitamin B6,100 mg vitamin E) on inflammatory markers, hemorheological parameters, platelet aggregation, von Willebrand factor activity as a marker of endothelium dysfunction, plasma lipids, plasma levels of folic acid, vitamin B12 and homocysteine (hcy), flow mediated vasodilatation (FMD) and thickness of carotis intima-media after 1 and 6 months of treatment in patients with vascular diseases (10 patients took 1 capsule, 10 patients 2 capsules of Sclerovit and 10 patients placebo) was determined. Plasma level of vitamin B12, folic acid and elongation index of red blood cells (RBC) increased significantly (p<0.05–0.001), hcy and triglyceride concentrations decreased significantly (p<0.05–0.001) in patients taking Sclerovit. HDL-cholesterol, RBC count, hematocrit, plasma and whole blood viscosity increased significantly (p<0.05–0.001) both in patients taking placebo or vitamins. Fibrinogen and CRP showed a significant (p<0.05–0.01) increase in patients on placebo, but did not change in patients on Sclerovit therapy. FMD showed a significant (p<0.05) amelioration in patients on 1 capsule of Sclerovit. Beside the favorable effects of Sclerovit on some of the measured parameters, the observed deterioration in hemorheological parameters can correlate with the contradictory results of large prospective studies with vitamins.
Keywords: Homocysteine, endothelial dysfunction, hemorheological parameters, platelet aggregation, folic acid, vitamin B_6, vitamin B_12
DOI: 10.3233/CH-2009-1182
Journal: Clinical Hemorheology and Microcirculation, vol. 42, no. 1, pp. 19-28, 2009
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl